Cargando…

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

BACKGROUND: We modified and evaluated an advance care planning (ACP) intervention, which had been shown to improve compliance with patient’s end of life (EoL) wishes, in a different patient population. METHODS: Patients with incurable cancer, and a Family Member (FM), were randomised one-to-one to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Stephanie B., Butow, Phyllis N., Bell, Melanie L., Detering, Karen, Clayton, Josephine M., Silvester, William, Kiely, Belinda E., Clarke, Stephen, Vaccaro, Lisa, Stockler, Martin R., Beale, Phillip, Fitzgerald, Natalie, Tattersall, Martin H. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251033/
https://www.ncbi.nlm.nih.gov/pubmed/30369600
http://dx.doi.org/10.1038/s41416-018-0303-7
_version_ 1783373031093043200
author Johnson, Stephanie B.
Butow, Phyllis N.
Bell, Melanie L.
Detering, Karen
Clayton, Josephine M.
Silvester, William
Kiely, Belinda E.
Clarke, Stephen
Vaccaro, Lisa
Stockler, Martin R.
Beale, Phillip
Fitzgerald, Natalie
Tattersall, Martin H. N.
author_facet Johnson, Stephanie B.
Butow, Phyllis N.
Bell, Melanie L.
Detering, Karen
Clayton, Josephine M.
Silvester, William
Kiely, Belinda E.
Clarke, Stephen
Vaccaro, Lisa
Stockler, Martin R.
Beale, Phillip
Fitzgerald, Natalie
Tattersall, Martin H. N.
author_sort Johnson, Stephanie B.
collection PubMed
description BACKGROUND: We modified and evaluated an advance care planning (ACP) intervention, which had been shown to improve compliance with patient’s end of life (EoL) wishes, in a different patient population. METHODS: Patients with incurable cancer, and a Family Member (FM), were randomised one-to-one to usual care or usual care plus an ACP intervention, between April 2014 and January 2017. Oncologists and participants were non-blinded. ACP was based on the Respecting Patient Choices model, with an offer to provide individualised ranges for typical, best-case and worst-case scenarios for survival time. Seven facilitators (two oncology nurses, two nurses and three allied health professionals) delivered the intervention within 2 weeks of study enrolment. The primary outcome measure, assessed by interviewing the FM 3 months after patient death, was the FM perception that the patient’s wishes were discussed, and met. RESULTS: Six hundred and sixty-five patients from seven Australian metropolitan oncology centres were referred for consideration by their oncologists, 444 (67%) met the study inclusion criteria and were approached by a study researcher. Two hundred and eight patients (47%) and their FM entered the trial as dyads. Fifty-three (46%) dyads in the ACP group and 63 (54%) dyads in the usual-care group had complete primary outcome data (p = 0.16). Seventy-nine patients and 53 FMs attended an ACP discussion. Mean length of discussion was 57 min. FMs from 23 (43%) dyads allocated to ACP and 21 (33%) dyads allocated usual care reported the patient’s EoL wishes were discussed and met (difference 10%, 95% CI: −2 to 8, p = 0.27). There were no differences in EoL care received, patient satisfaction with care; FM satisfaction with care or with death; or FM well being. Rates of palliative care referral were high in both groups (97% vs 96%). CONCLUSIONS: A formal ACP intervention did not increase the likelihood that EoL care was consistent with patients’ preferences.
format Online
Article
Text
id pubmed-6251033
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62510332019-10-29 A randomised controlled trial of an advance care planning intervention for patients with incurable cancer Johnson, Stephanie B. Butow, Phyllis N. Bell, Melanie L. Detering, Karen Clayton, Josephine M. Silvester, William Kiely, Belinda E. Clarke, Stephen Vaccaro, Lisa Stockler, Martin R. Beale, Phillip Fitzgerald, Natalie Tattersall, Martin H. N. Br J Cancer Article BACKGROUND: We modified and evaluated an advance care planning (ACP) intervention, which had been shown to improve compliance with patient’s end of life (EoL) wishes, in a different patient population. METHODS: Patients with incurable cancer, and a Family Member (FM), were randomised one-to-one to usual care or usual care plus an ACP intervention, between April 2014 and January 2017. Oncologists and participants were non-blinded. ACP was based on the Respecting Patient Choices model, with an offer to provide individualised ranges for typical, best-case and worst-case scenarios for survival time. Seven facilitators (two oncology nurses, two nurses and three allied health professionals) delivered the intervention within 2 weeks of study enrolment. The primary outcome measure, assessed by interviewing the FM 3 months after patient death, was the FM perception that the patient’s wishes were discussed, and met. RESULTS: Six hundred and sixty-five patients from seven Australian metropolitan oncology centres were referred for consideration by their oncologists, 444 (67%) met the study inclusion criteria and were approached by a study researcher. Two hundred and eight patients (47%) and their FM entered the trial as dyads. Fifty-three (46%) dyads in the ACP group and 63 (54%) dyads in the usual-care group had complete primary outcome data (p = 0.16). Seventy-nine patients and 53 FMs attended an ACP discussion. Mean length of discussion was 57 min. FMs from 23 (43%) dyads allocated to ACP and 21 (33%) dyads allocated usual care reported the patient’s EoL wishes were discussed and met (difference 10%, 95% CI: −2 to 8, p = 0.27). There were no differences in EoL care received, patient satisfaction with care; FM satisfaction with care or with death; or FM well being. Rates of palliative care referral were high in both groups (97% vs 96%). CONCLUSIONS: A formal ACP intervention did not increase the likelihood that EoL care was consistent with patients’ preferences. Nature Publishing Group UK 2018-10-29 2018-11-13 /pmc/articles/PMC6251033/ /pubmed/30369600 http://dx.doi.org/10.1038/s41416-018-0303-7 Text en © Cancer Research UK 2018 https://creativecommons.org/licenses/by/4.0/Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Article
Johnson, Stephanie B.
Butow, Phyllis N.
Bell, Melanie L.
Detering, Karen
Clayton, Josephine M.
Silvester, William
Kiely, Belinda E.
Clarke, Stephen
Vaccaro, Lisa
Stockler, Martin R.
Beale, Phillip
Fitzgerald, Natalie
Tattersall, Martin H. N.
A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title_full A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title_fullStr A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title_full_unstemmed A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title_short A randomised controlled trial of an advance care planning intervention for patients with incurable cancer
title_sort randomised controlled trial of an advance care planning intervention for patients with incurable cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251033/
https://www.ncbi.nlm.nih.gov/pubmed/30369600
http://dx.doi.org/10.1038/s41416-018-0303-7
work_keys_str_mv AT johnsonstephanieb arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT butowphyllisn arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT bellmelaniel arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT deteringkaren arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT claytonjosephinem arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT silvesterwilliam arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT kielybelindae arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT clarkestephen arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT vaccarolisa arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT stocklermartinr arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT bealephillip arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT fitzgeraldnatalie arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT tattersallmartinhn arandomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT johnsonstephanieb randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT butowphyllisn randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT bellmelaniel randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT deteringkaren randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT claytonjosephinem randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT silvesterwilliam randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT kielybelindae randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT clarkestephen randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT vaccarolisa randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT stocklermartinr randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT bealephillip randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT fitzgeraldnatalie randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer
AT tattersallmartinhn randomisedcontrolledtrialofanadvancecareplanninginterventionforpatientswithincurablecancer